来自Cirsium setosum的干北烯酸及其抗炎活性
Qing-Jiang Xu1, Jia-Chen Liu1, Cheng-Jin Huang1
1College of Applied Arts and Science, Beijing Union University, Beijing 100191, China.
Fitoterapia
|February 28, 2024
概括
来自Cirsium setosum的五种新型二次北二类物质表现出抗炎性质. 化合物1在刺激细胞中表现出最强烈的氧化物 (NO) 生产抑制.
科学领域:
- 自然产品 化学 化学
- 药理学 药理学是指药理学的学科.
背景情况:
- (Cirsium setosum) 是一种具有潜在药用功能的植物物种.
- 三类是众所周知的有着多种生物活性的一类化合物.
研究的目的:
- 从Cirsium setosum中分离和描述新型的二极北类.
- 为了评估这些孤立化合物的抗炎潜力.
主要方法:
- 使用色谱技术分离化合物.
- 通过光谱方法 (NMR,MS) 阐明结构.
- 在体外抗炎测定使用脂聚糖刺激的RAW 264.7细胞来测量氧化 (NO) 生产.
主要成果:
- 五种不寻常的seco-nortriterpenoids,命名为1-5,成功地被隔离和鉴定出来.
- 化合物1-5显示出对NO产生的显著抑制作用.
- 化合物1在测试化合物中表现出最强的抗炎活性.
- 这项研究报告了首次发现来自Cirsium属的二三基结构.
结论:
- 从Cirsium setosum中分离出来的seco-nortriterpenoids具有显著的抗炎活性.
- 化合物1是作为抗炎剂进一步研究的有希望的候选物.
- 这些发现扩大了Cirsium属三类的化学多样性.
相关概念视频
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
246
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
246
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
118
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
118
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
137
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
137
Drugs for Treatment of Ulcerative Colitis in IBD
141
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
141
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
388
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
388
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
252
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
252


